Beta Drugs Fund Raise
Beta Drugs Limited provided a shareholding clarification regarding its proposed preferential issue. Following the issuance of equity shares and conversion of CCDs, the total share capital will increase to 1,10,85,872 shares, with promoter holding adjusting from 64.63% to 59.10%.